A kind of active substance sustained-release material system for tissue repair and preparation method thereof

A technology for tissue repair and active substances, applied in prostheses, drug delivery, pharmaceutical formulations, etc., can solve the great demand for combined application of multiple repair factors, low coating rate of water-soluble drugs, and limited application range of BG and other problems, to achieve the effect of improving the singleness of the sustained-release content, good repairing effect, and easy shaping

CN110124103BInactive Publication Date: 2021-07-23SHANGHAI JIAOTONG UNIV
0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Publication Date
2021-07-23
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to the fields of biomedical materials, tissue engineering and medicine, and discloses an active substance slow-release material system for tissue repair. The active substance slow-release material system consists of three parts: an outer layer, a middle layer and an inner layer. The layer is a sodium alginate / bioactive glass / gluconolactone composite injectable hydrogel layer, the middle layer is a sodium alginate hydrogel microsphere layer wrapped with a repair factor, and the inner layer is a polylactic acid-hydroxyl layer wrapped with a drug. Acetic acid copolymer microsphere layer. The invention also discloses a preparation method of the active substance slow-release material system. The active substance sustained-release material system of the present invention can release the repair factors and drugs wrapped inside the material in an orderly manner according to the different stages of tissue regeneration in the wound repair process, and provide the corresponding active substances required for tissue regeneration in different stages, and can Better play the combined effect of repair factors.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to the fields of biomedical materials, tissue engineering and medicine, in particular to the preparation of a multi-layer active substance slow-release material system and its application in tissue regeneration and repair. Background technique

[0002] Tissue engineering is divided into in vitro tissue engineering and in vivo tissue engineering. In vitro tissue engineering requires a large number of seed cells and growth factors. However, there are many problems in the extraction and in vitro expansion of seed cells. It is difficult to obtain high-quality and sufficient seed cells, and the half-life of growth factors is short, expensive, and their behavior is difficult to control when used in vivo. In order to solve these problems, from the perspective of material design, a "tissue-inducing" biomaterial is prepared, which itself has bioactive materials, and the material is directly implanted in the body, and the bioactivity of the...

Examples

Embodiment 1

[0045] The raw materials and equipment used in this example are all known products obtained by purchasing commercially available products. The following SA refers to sodium alginate, ALG refers to calcium alginate, PLGA refers to polylactic acid-glycolic acid copolymer, BG refers to bioactive glass, GDL refers to gluconolactone, CM refers to conditioned medium, and PVA refers to polyvinyl alcohol.

[0046] Bioactive glass is a kind of bioactive glass containing Ca, Si, P ternary system, which has the characteristics of controllable mechanical properties, degradation rate and good biological activity of bioactive glass.

[0047] Gluconolactone is a coagulant and can be used as a pharmaceutical additive. It has the characteristics of non-toxicity, oral administration, and good curing effect, and can be used in pharmaceutical preparations.

[0048] The inner layer of polylactic acid-glycolic acid copolymer / scar inhibitory factor or drug / additive microsphere layer can be abbreviat...